Scientists develop New Platform Technology for Personalized Cancer Therapy
The work by Distinguished Professor Kyungjae Myung's team has been published in PNAS. A new therapy called CINDELA (Cancer-Specific InDel Attacker) employs CRISPR-Cas9 to kill cancer cells without affecting normal tissues. Diagnosis of cancers may be one of the worst news to patients and their families. Conventional...